XML 38 R24.htm IDEA: XBRL DOCUMENT v3.22.0.1
Organization, Business and Basis of Presentation - Additional Information (Detail)
$ in Thousands
12 Months Ended
Dec. 31, 2021
USD ($)
Segment
Dec. 31, 2020
USD ($)
Description Of Business [Line Items]    
Accumulated deficit $ 372,296 $ 338,528
Cash, cash equivalents and available-for-sale investments 107,900  
Other receivables $ 435 $ 2,039
Number of operating segment | Segment 1  
Pangu BioPharma [Member] | Hong Kong [Member]    
Description Of Business [Line Items]    
Majority-owned subsidiary percentage 98.00%